Search results

Learn how fundraising works for limited liability companies, including the differences between funding for LLCs vs. corporations, and what types of investors are available.

Learn the differences between pre-money and post-money valuations for private companies and how to calculate preferred share price when pitching investors during a priced round.

IPOs are the lifeblood of venture capital, but they've been few and far between in recent years. Investors are watching to see if the success of some recent high-profile listings will provide a much-needed spark.

Health and biotech VC fundraising surged in the aftermath of the COVID-19 pandemic and has stood strong against market headwinds.

After two-plus years of steady declines, the Series C market may be bouncing back.

These days, investors have more leverage than startups in deal negotiations. How are they choosing to use it?

The geographic diversification of VC has been a developing trend in recent years. Q1 2024 showed a possible reversal.

At Series D and later, VC deal activity slowed down in Q1 2024. There are reasons for the decline on both sides of the negotiating table.

The venture capital fundraising market remained slow in Q1 2024, but valuations held steady or climbed at almost every stage.

Fundraising for pre-seed companies stayed robust in Q1 2024, dominated by SAFEs and convertible notes; valuation caps remained flat.

The median venture round size increased at every stage from seed to Series C during Q1 2024, a welcome development for cash-hungry startups.